Corporate Corruption News Articles

Excerpts of key news articles on

Below are key excerpts of revealing news articles on corporate corruption from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

Note: Explore our full index to revealing excerpts of key major media news articles on dozens of engaging topics. And read excerpts from 20 of the most revealing news articles ever published.

A Ninth Circuit panel on Wednesday rolled back the Environmental Protection Agency's approval of the use of the pesticide streptomycin sulfate on citrus groves to fight citrus disease. The underlying lawsuit was brought by farmworkers and other interest groups, which argued the EPA had greenlit streptomycin sulfate for use on citrus plants without adequately considering potential harms from the chemical. The panel, consisting of U.S. Circuit Judges Ronald Gould and Johnnie Rawlinson ... and Daniel Bress ... partially ruled in favor of the EPA – determining there was substantial evidence for the EPA's assessment concerning risks which could lead to antibiotic resistance. However, they said, the EPA's assessment concerning risks to bees and other pollinators was incomplete. In a statement after the ruling, the Center for Biological Diversity, one of the groups involved in the suit, applauded the Ninth Circuit's decision. The rollback of streptomycin approval "is a significant win for public health, farmworker safety and endangered species," [said attorney] Hannah Connor. Streptomycin sulfate is used as an antibiotic to treat serious illnesses but has also found use as a pesticide. The Center for Biological Diversity claims spraying streptomycin on citrus trees to combat citrus greening disease is "highly ineffective" and argues that its use as a pesticide violates the Endangered Species Act because it causes long-term health effects to endangered animals and plants.

Note: For more along these lines, see concise summaries of deeply revealing news articles on health and government corruption from reliable major media sources.

It is against the law to use paraquat in China, Switzerland, the United Kingdom and dozens of other countries. Many countries have banned the herbicide due to its extreme toxicity, while others have expressed concerns over the possible risk for Parkinson's disease. Yet the herbicide, manufactured by a Swiss company that is owned by the Chinese state, is still widely used throughout the United States in part because it is a highly effective way to kill weeds. The company, Syngenta, says that paraquat, which it produces under the name Gramoxone, "is safe for its intended and labelled use." Clayton Tucholke, who used Gramoxone for years on his farm in LaBolt, South Dakota, and has since been diagnosed with Parkinson's disease, says otherwise. "It should have been pulled, I think, you know, so it didn't happen to somebody else," Tucholke told ABC News. The Tucholkes are among the more than 4,000 Americans who have filed lawsuits as part of a multi-district litigation against Syngenta, which currently manufactures Gramoxone, and Chevron, which distributed it in the U.S. from 1966 until 1986. Although Syngenta and Chevron told ABC News that there is no scientific evidence that supports a causal link between paraquat and Parkinson's disease, the Tucholkes and other plaintiffs allege that such a link exists, arguing that Syngenta and Chevron knew or should have known that the herbicide could "cause severe neurological injuries."

Note: Internal corporate documents reveal how global chemical giant Syngenta secretly influenced scientific research regarding links between its top-selling weedkiller and Parkinson's disease. For more along these lines, see concise summaries of deeply revealing news articles on health and food system corruption from reliable major media sources.

If you count all the contracts for private industry from U.S. Customs and Border Protection (CBP) and U.S. Immigration and Customs Enforcement (ICE) since Joe Biden took office – for, that is, 2021, 2022, and 2023 – the number comes to $23.5 billion. And though you'd never guess it, given what we normally hear, that already beats Donald Trump's total for his full four years in office, $20.9 billion. Or, to put the matter in a more historical perspective, private contracts for the Biden years already top the cumulative $22.5 billion spent in border and immigration enforcement budgets from 1975 to 1997. Budgets and private-sector contracts tell an all-too-familiar story in which the border-enforcement apparatus only continues to grow ever larger, regardless of who's president. As 2023 nears its end, there have simply never been as many opportunities to make a killing (figuratively as well as literally) by surveilling, arresting, caging, and expelling people from this country. In 2023, there were 8,033 such opportunities – and I'm speaking here about contracts in play – or about 22 contracts a day. 1,421 remains of dead people were recovered along the border during Biden's first two years in office, higher in other words than the 1,133 during Trump's full four years. Imagine the national news stories, if the remains of nearly 1,500 hikers had been found in the Southwest during a two-year period. But for migrants in those ever more profitable, ever deadlier borderlands, mum's the word.

Note: Carlos Arellano is a whistleblower and former immigration contractor, who alleges that the US government is the largest trafficker of children in the world. Watch an interview of Arellano share his shocking experiences at some of the immigration facilities. For further exploration of this troubling topic, read about MVM Inc, the ex-CIA defense contractor making millions of dollars hauling children away from the Mexico border on commercial airline flights. Where is the transparency about what is happening to these children?

Anti-vaccine advocates have recently made allegations against the Pfizer COVID-19 vaccine in hopes that the charges may hurt the drug manufacturer. In a series of posts on X (formerly Twitter), Steve Kirsch expressed concern over reports that Pfizer's vaccine was contaminated, saying that the Food and Drug Administration (FDA) "is now at a crossroads." "Either they admit that they knew about the plasma contamination, and failed to disclose that to the public and to the outside committees, or they can claim that they didn't know about it in which case Pfizer is liable. But we have the Pfizer documents that were given to the FDA so we know what the FDA got," Kirsch wrote. "I seriously doubt there's any disclosure of SV40 contamination. That means we have an adulterated vaccine and the FDA has to remove it from the market until the adulteration is fixed. If the FDA doesn't do that, they should face criminal prosecution for endangering the public, and not following the law." (SV40 refers to simian virus 40.) In his posts, Kirsch also references an incident in Michigan where a judge ruled that the manufacturer of the COVID-19 medication Remdesivir was no longer protected by the federal Public Readiness and Emergency Preparedness (PREP) Act after a man filed a lawsuit against the manufacturer. The man filed the suit after suffering strokes and an amputation following treatment with the drug, Remdesivir, which was contaminated with glass particles.

Note: While the data is still being uncovered, read an in-depth, scientific investigation into vaccine contamination, including concerns that Pfizer hid this contamination from regulators. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.

Ever since Israel responded to Hamas's atrocities with a vicious onslaught that has killed more than 8,000 Palestinians there has been an attempt to silence, intimidate and harass Palestinian sympathisers. Inevitably, it is Palestinians who suffer the brunt of a campaign to stigmatise even the most basic opposition to the mass slaughter of their people. Viet Thanh Nguyen, the son of refugees and a sympathiser with other displaced people, had a talk at the 92nd Street Y centre in New York postponed after he signed an open letter demanding an "end to the violence and destruction in Palestine". What of the US Campaign for Palestinian Rights, whose longstanding conference in Houston was cancelled following the Orthodox Jewish Chamber of Commerce describing the event as "a conference for Hamas supporters"? The Hilton cited security concerns as the reason for the cancellation. The keynote speaker, Rashida Tlaib, the first ever elected Palestinian-American congresswoman, has been targeted by a Republican smear campaign, with an attempt to censure her for "antisemitic activity" and "sympathising with terrorist organisations" – all baseless attacks. Meanwhile, MSNBC reportedly stopped three of its Muslim broadcasters from presenting their shows, with no explanation. The broadcaster claimed any change in programming as "coincidental". This intimidation has deadly consequences: it undermines public pressure on Israel's western allies to stop the slaughter and end the occupation.

Note: For more along these lines, see concise summaries of deeply revealing news articles on war and media manipulation from reliable sources.

Companies that make popular weight loss shots like Ozempic and Mounjaro are starting to test a version for kids as young as six years old who suffer from obesity. Pharmaceutical company Eli Lilly signaled its plans to start clinical trials with Mounjaro for kids ages 6-11, over the weekend. Novo Nordisk, the company that makes Ozempic, reported it is in phase three of testing Saxenda, a version of its drug for children ages 6-12. The rates of obesity for children in the U.S. have tripled since the 1980s, affecting close to 15 million children nationwide, according to the CDC. This is nearly one in five kids. "It's unlikely it's going to do much if you just give them the medication. You need to instill all these behavior changes, lifestyle changes, talk about the diet, nutrition consults, the exercise," said pediatrician Dr. Alison Mitzner. The concern for possible long-term impacts and side effects is one nutritionist Carrie Lupoli echoes. Both drug companies were sued earlier this year after a plaintiff said she suffered stomach paralysis. "It's scary to me that we are going down that path instead of actually working on the root cause because we know weight gain is a symptom of health and hormones," Lupoli said. CDC data shows kids may have gained weight twice as fast during the pandemic. Earlier this year, the American Academy of Pediatrics came out with new guidance that includes medication and surgery as suggestions for patients 12 and up suffering from obesity.

Note: The pharmaceutical companies behind these weight loss drugs are raking it in despite significant efficacy and safety concerns. Sales of Ozempic generated revenue of $3.2 billion in the second quarter (up from $2.1 billion during the same period in 2022) and Mounjaro generated $980 million in sales for the company during the second quarter (a 72% increase compared to the first quarter). For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.

Braven Environmental [is] a company that says it can recycle nearly 90 percent of plastic waste through a form of chemical recycling called pyrolysis. Traditional recycling is able to process only about 8.7 percent of America's plastic waste; pyrolysis uses high temperatures and low-oxygen conditions to break down the remaining plastics, like films and Styrofoam, ideally turning them into feedstock oil for new plastic production. The American Chemistry Council, the country's leading petrochemical industry trade group, claims that chemical recycling will create a "circular economy" for the bulk of the world's plastic, diverting it from oceans and landfills. Plastic giants have gone so far as to dub the process "advanced recycling," but environmentalists say this is a misnomer because the majority of the plastic processed at such facilities is not recycled at all. In fact, researchers have found that the process uses more energy and has a worse overall environmental impact than virgin plastic production. Despite these challenges, lawmakers nationwide are now embracing the technology, thanks to a massive lobbying push from ... petrochemical groups. One list of warnings in a Braven air permit application reads like a toxicologist's worst nightmare: The pyrolysis oil may cause cancer and genetic defects, as well as damage to organs, fertility, and unborn children. Other hazards included being "extremely flammable" and "very toxic to aquatic life" with "long lasting effects."

Note: For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption from reliable major media sources.

Nearly three months into taking Ozempic for diabetes, Jenny Kent had already lost 12 pounds, and her blood sugar numbers were looking better than they had in a while. Ozempic, the injectable drug approved for Type 2 diabetes, has taken the world by storm. Despite not being approved by the Food and Drug Administration for weight loss, Ozempic has prompted people on TikTok and Instagram to speculate about which stars have used it to shed pounds seemingly overnight. But for Kent something else changed after she started taking Ozempic. "I was just constantly in a state of being overwhelmed," says Kent. "So my response to that was just I was just crying all the time. Sobbing, crying ... I still didn't put it together, so I kept ... taking my injections." She's one of many people taking Ozempic and related drugs who describe mental health problems. But that side effect isn't mentioned in Ozempic's instructions for use, or drug label. In July, the European Medicines Agency said that it was looking into the risk of thoughts of self-harm and suicidal thoughts with the use of Ozempic and similar drugs. The FDA hasn't taken that step. NPR analyzed the FDA's adverse event reporting system, or FAERS, and learned that the agency has received 489 reports of patients experiencing anxiety, depression or suicidal thoughts while taking semaglutide drugs, including Ozempic, Wegovy and Rybelsus. In 96 of those reports, the patient had suicidal thoughts. Five of them died.

Note: A deeper investigation explores the concerning scope of health issues related to weight-loss drug side effects. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.

France's radiation watchdog has banned sales of Apple's iPhone 12 after tests that it said showed the smartphone breached European radiation exposure limits. The Agence Nationale des Frequences (ANFR) said on Tuesday the model's Specific Absorption Rate (SAR) - a measure of the rate of radiofrequency energy absorbed by the body from a piece of equipment - was higher than legally allowed. Jean-Noel Barrot, France's junior minister for the digital economy, told newspaper Le Parisien a software update could fix the problem. If Apple does not resolve the issue, the ANFR said it would order a recall of the device across France. "Specific Absorption Rate" refers to the dose of energy that the body absorbs from any source of radiation. It is expressed as watts per kilogram of body weight. The radiation from mobile phones is a result of the way they work, by transmitting radiofrequency waves, creating electromagnetic fields. The ANFR said it recently carried out random tests on 141 phones, including iPhone 12, bought from shops. In independent laboratory tests, two iPhone 12s did not comply with EU standards, the office of the Digital Minister told Reuters. Smartphone radiation tests have so far led to 42 imposed sale stops in the country, it said. The ANFR said accredited labs had found an SAR of 5.74 watts per kilogram during tests of the iPhone 12 being held in the hand or kept in a trouser pocket. The EU standard is 4.0 watts per kilogram.

Note: Explore an excellent investigation into how the FCC shields cell phone companies from valid safety concerns. This Wired article quotes the result of a mega-study that reveals there is "significant evidence linking cellular phone use to increased tumor risk." Unlike the U.S., many countries have regulations in place to protect people from cell phone radiation exposure. Check out this comprehensive list of countries with official recommendations and policies on cell phone radiation exposure. For more along these lines, see concise summaries of news articles on wireless technology risks from reliable major media sources.

Google fought hard to be the default search engine on smartphones and browsers so it "can manipulate your choices," an expert on human behavior testified for the government at the closely watched antitrust trial. Antonio Rangel, a behavioral economist ... took the stand for the second day and said Google has leaned heavily on default settings to keep users hooked on its search engine and other lucrative services. The Justice Department is arguing ... that the Alphabet unit sought agreements with mobile carriers to win powerful default positions on smartphones to dominate search. The antitrust case – the largest of its kind in more than two decades – will ultimately hinge on whether Google is determined to have taken anticompetitive steps to cut off rivals while building its search behemoth. In testimony on Wednesday, Rangel questioned Google's argument that users could easily switch their default search engine, telling the court that he acquired an Android smartphone and found that it took 10 steps for the owner to switch Google for Microsoft's Bing. "That is considerable choice friction," Rangel said. Justice Department attorneys said Google paid "more than $10 billion per year" to major companies, including smartphone makers Apple and Samsung, browser operators like Mozilla and wireless providers such as AT&T, to secure a 91% share of the search market. The case's outcome won't be determined by a jury. Instead, US District Judge Amit Mehta will reach a determination on the outcome.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and media manipulation from reliable sources.

At the heart of America's political and cultural turmoil is a crisis of trust. In the space of a generation, the people's confidence in their leaders and their most important institutions to do the right thing has collapsed. The federal government, big business, the media, education, science and medicine, technology, religious institutions, law enforcement and others have seen a precipitous decline. Since 1979 Gallup has measured trust among the public in the most important American institutions. Its latest survey ... found that across the nine key institutions Gallup has tracked consistently, the proportion of Americans who said they had "a great deal or quite a lot of confidence" averaged out at 26%. That is the lowest figure ever recorded. Some institutions have forfeited more trust than others. In 1979 Gallup found that 51% of Americans had a great deal or quite a lot of confidence in newspapers. This year the number was 18%. The biggest factor driving mistrust ... is surely the widening cultural gap between the people who have led and thrived in our major institutions and the rest of the population. The past 20 years have seen the rapid emergence of a new elite–expensively educated, versed in progressive nostrums, increasingly distant from and disdainful of the rest of America and its values. This crowd comprises much of the nation's permanent government classes, almost its entire academic establishment, most of the people who control its news and cultural output, and a good deal of its corporate elite.

Note: About half of Americans lost faith in the scientific community after this "new elite" repeatedly misled the public on issues related to the pandemic. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and media manipulation from reliable sources.

The cashless society is effectively already a reality for most of us, but there remains a minority for whom it represents a continuing headache. The government last week told high street banks that they must offer access to cash machines within three miles of customers after the closure of thousands of branches had reduced the number of ATMs. There are also an estimated to be 1.3 million adults in this country who are "unbanked" – ie do not have a bank account. For them, something as mundane as parking a car is increasingly fraught – a quarter of London councils have removed pay and display parking machines in favour of smartphone-centred apps. The shiny, bright future of full computerisation looks very much like a dystopia to someone who either doesn't understand it or have the means to access it. And almost by definition, the people who can't access the digitalised world are seldom visible, because absence is not easy to see. What is apparent is that improved efficiency doesn't necessarily lead to greater wellbeing. Technology doesn't have to be dehumanising, but if it's to avoid that outcome it has to be human-focused, not just consumer-focused, and in particular not just digital-consumer-focused. Cash, like printed air tickets or indeed train tickets, will no doubt one day soon seem as anachronistic as the barter system. In the meantime the transition should focus on ensuring that no one is discounted because they are too old, too poor or too disabled to matter to the gods of efficiency.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and income inequality from reliable major media sources.

In May, the World Health Organization issued an alarming report that declared widely used non-sugar sweeteners like aspartame are likely ineffective for weight loss, and long term consumption may increase the risk of diabetes, cardiovascular diseases and mortality in adults. A few months later, WHO declared aspartame, a key ingredient in Diet Coke, to be a "possible carcinogen", then quickly issued a third report that seemed to contradict its previous findings – people could continue consuming the product at levels determined to be safe decades ago. That contradiction stems from beverage industry corruption of the review process by consultants tied to an alleged Coca-Cola front group, the public health advocacy group US Right to Know said in a recent report. It uncovered eight WHO panelists involved with assessing safe levels of aspartame consumption who are beverage industry consultants who currently or previously worked with the alleged Coke front group, International Life Sciences Institute (Ilsi). Aspartame was first approved for use in the US in the early 1980s over the objection of some researchers who warned of potential health risks. In recent years, as evidence of health threats has mounted, industry has ramped up a PR campaign to downplay the issues. Ilsi representatives have sought to shape food policy worldwide. [Gary Ruskin, US Right to Know's executive director], characterized the aspartame controversy as a "masterpiece in how Ilsi worms its way into these regulatory processes".

Note: Explore a comprehensive overview of key scientific studies on aspartame harms, and how they were covered up by the sugar industry. For more along these lines, see concise summaries of deeply revealing news articles on corruption in the food system and in the corporate world from reliable major media sources.

Each year for the last 26 years – nearly his entire tenure in the US Congress – Earl Blumenauer has advocated for a law that would utterly transform US agriculture. Nearly every time, though, his proposals have been shut down. Even so, he persists. Blumenauer, a Democrat from Oregon, wants to see a version of US agriculture that centers people, animals and the environment, rather than the large-scale, energy-intensive commodity crop farms that currently receive billions of dollars in subsidies. Blumenauer's newest plan, the Food and Farm Act, was introduced earlier this year, as an alternative to the farm bill – the package of food and agricultural policies passed every five years that is up for renewal this fall. His proposal would redirect billions of dollars away from subsidies for commodity farms towards programs that support small farmers, climate-friendly agriculture and increasing healthy food access. "Most of us don't even know that the public dollars initially designed to protect farmers and keep supply managed to feed a hungry nation in the Great Depression are now reinforcing wealthy agribusiness corporations to grow commodities that are not even meant for human consumption," said Joshua Newell, a policy analyst. Most of the farms excluded from subsidy payments are those using sustainable growing methods that preserve soil and benefit the climate. Blumenauer's bill would ... ensure more funding goes toward sustainable farming practices.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in the food system from reliable major media sources.

A number of hospitals have been sued for refusing to allow patients dying of COVID to receive treatment with ivermectin. If the hospital lost, it appealed the decision, even if the patient did receive ivermectin and recover, according to attorney Andrew Schlafly in the summer issue of the Journal of American Physicians and Surgeons. "Hospitals wanted to establish precedents for their side, so that next time they could deny treatment by pointing to appellate decisions in their favor," Schlafly writes. They adopted a "strategy of seeking to establish precedents that increased their authority, and to remove any precedents against unlimited power for them." Ivermectin is a long-established safe drug that is widely used to treat parasitic infections. It has also been shown to have antiviral activity. Many physicians have reported successful use in COVID patients, and many though not all studies have shown safety and benefit. Many state appellate courts cite the Food and Drug Administration's (FDA's) disparagement of ivermectin as a legal basis for hospitals to deny access by dying patients to this drug, long approved by the FDA as safe. Schlafly writes that the FDA has "been able to evade judicial review for too long. The more the FDA avoids submitting to discovery procedures that are commonplace for every other defendant, the bigger the mushrooms can grow in the dark at this federal agency."

Note: Explore a comprehensive look into the benefits and uses of ivermectin, despite establishment media's concerted effort to discredit its efficacy and safety. For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and the coronavirus from reliable major media sources.

JPMorgan Chase reached a tentative settlement with sexual abuse victims of Jeffrey Epstein, the deceased financier, after weeks of embarrassing disclosures about the bank's longstanding relationship with him. David Boies, one of the lead lawyers for the victims, said the bank was prepared to pay $290 million to resolve the lawsuit. The proposed deal would settle a lawsuit filed ... on behalf of victims who were sexually abused by Mr. Epstein over a roughly 15-year period when they were teenage girls and young women. The number of victims could potentially rise to more than 100. JPMorgan still faces a related lawsuit by the government of the U.S. Virgin Islands. That suit remains the biggest outstanding Epstein-related case after years of lawsuits against Mr. Epstein's estate and Ghislaine Maxwell's conviction in 2021 in Manhattan federal court for helping Mr. Epstein engage in sex trafficking. The lawsuit filed by the victims claimed that JPMorgan ignored repeated warnings that Mr. Epstein had been trafficking teenage girls and young women for sex, even after he registered as a sex offender and pleaded guilty in a 2008 Florida case to soliciting prostitution from a teenage girl. The complaint said the bank had overlooked red flags in Mr. Epstein's activity because it valued him as a wealthy client who had access to dozens of even wealthier people. Legal documents revealed that after designating Mr. Epstein a "high risk client" in 2006, the bank kept him on as a customer.

Note: One Nation Under Blackmail is a new book by Whitney Webb, an investigative journalist who explores the deep ties between Jeffrey Epstein and US and Israeli Intelligence criminal networks. For more along these lines, see concise summaries of news articles on Jeffrey Epstein's child sex ring from reliable major media sources.

These blank-looking warehouses are home to an artificial intelligence (AI) company used by the Government to monitor people's posts on social media. Logically has been paid more than Ł1.2 million of taxpayers' money to analyse what the Government terms "disinformation" – false information deliberately seeded online – and "misinformation", which is false information that has been spread inadvertently. It does this by "ingesting" material from more than hundreds of thousands of media sources and "all public posts on major social media platforms", using AI to identify those that are potentially problematic. It has a Ł1.2 million deal with the Department for Culture, Media and Sport (DCMS), as well as another worth up to Ł1.4 million with the Department of Health and Social Care to monitor threats to high-profile individuals within the vaccine service. Other blue-chip clients include US federal agencies, the Indian electoral commission, and TikTok. It also has a "partnership" with Facebook, which appears to grant Logically's fact-checkers huge influence over the content other people see. A joint press release issued in July 2021 suggests that Facebook will limit the reach of certain posts if Logically says they are untrue. "When Logically rates a piece of content as false, Facebook will significantly reduce its distribution so that fewer people see it, apply a warning label to let people know that the content has been rated false, and notify people who try to share it," states the press release.

Note: For more along these lines, see concise summaries of deeply revealing news articles on government corruption and the disappearance of privacy from reliable major media sources.

With the U.S. supplying billions-of-dollars of munitions to Ukraine and growing tensions in the Taiwan Strait, some Pentagon generals are sounding alarms about the dwindling supply of U.S. weapons ... at a time when the cost of replacing them is skyrocketing. A six-month investigation by 60 Minutes found it has less to do with foreign entanglements than domestic ones - what can only be described as price gouging by U.S. defense contractors. It wasn't always like this. The roots of the problem can be traced to 1993, when the Pentagon, looking to cut costs, urged defense companies to merge. Fifty one major contractors consolidated to five giants. The landscape has totally changed. In the '80s, there was intense competition amongst a number of companies. And so the government had choices. They had leverage. We have limited leverage now. The problem was compounded when the Pentagon, in another cost saving move, cut 130,000 employees whose jobs were to negotiate and oversee defense contracts. The Pentagon granted companies unprecedented leeway to monitor themselves. Instead of saving money ... the price of almost everything began to rise. In the competitive environment before the companies consolidated, a shoulder fired stinger missile cost $25,000 in 1991. With Raytheon now the sole supplier, it costs more than $400,000 to replace each missile sent to Ukraine ... even accounting for inflation and some improvements that's a seven-fold increase. 

Note: Leading military contractors are hiking up prices of everyday products as well, costing US taxpayers more than $1.3 million in unnecessary markups. Explore how the Pentagon paid arms manufacturer Boeing over $200,000 for four trash cans used in surveillance planes (roughly $51,606 per unit).  War profiteering happens on many levels, as articulated in a summary of War is a Racket by General Smedley D. Butler.

For the past decade, the White House and Congress have relied on the National Academies of Sciences, Engineering and Medicine, a renowned advisory group, to help shape the federal response to the opioid crisis, whether by convening expert panels or delivering policy recommendations and reports. Yet officials with the National Academies have kept quiet about one thing: their decision to accept roughly $19 million in donations from members of the Sackler family, the owners of Purdue Pharma, the maker of the drug OxyContin that is notorious for fueling the opioid epidemic. The opioid crisis has led to hundreds of thousands of overdose deaths, spawned lawsuits and forced other institutions to publicly distance themselves from Sackler money or to acknowledge potential conflicts of interest from ties to Purdue Pharma. The National Academies has largely avoided such scrutiny as it continues to advise the government on painkillers. Institutions that more publicly examined their use of Sackler donations include Tufts University, which released a review of possible conflicts of interest related to pain research education funded by Purdue Pharma. Concerns noted in the report included a senior Purdue executive's delivering lectures to students each semester. The World Health Organization in 2019 retracted two guidance documents on opioid policy after lawmakers aired concerns about ties to opioid makers, including a Purdue subsidiary, among report authors and funders.

Note: For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.

In recent months, the Pentagon has moved to provide loans, guarantees, and other financial instruments to technology companies it considers crucial to national security – a step beyond the grants and contracts it normally employs. So when Silicon Valley Bank threatened to fail in March following a bank run, the defense agency advocated for government intervention to insure the investments. The Pentagon had even scrambled to prepare multiple plans to get cash to affected companies if necessary, reporting by Defense One revealed. Their interest in Silicon Valley Bank stems from the Pentagon's brand-new office, the Office of Strategic Capital. The secretary of defense established the OSC in December specifically to counteract the investment power of adversaries like China in U.S. technologies, and to secure separate funding for companies whose products are considered vital to national security. The national security argument for bailout, notably, found an influential friend in the Senate. As the Biden administration intervened to protect Silicon Valley Bank depositors on March 12, Sen. Mark Warner, D-Va., who chairs the powerful Senate Intelligence Committee and also sits on the Banking Committee, issued a press release warning that the bank run posed a national security risk. Warner – the only member of Congress to have publicly tied SVB to national security – has received significant contributions from the financial sector. Since 2012, Warner has received over $21,000 from Silicon Valley Bank's super PAC.

Note: Many tech startups with funds in Silicon Valley Bank were working on projects with defense and national security applications. Explore revealing news articles on the rising concerns of the emerging technologies that the Defense Department is investing in, given their recent request for $17.8 billion to research and develop artificial intelligence, autonomy, directed energy weapons, cybersecurity, 5G technology, and more.

Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.